![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 6
2022
Krop, Ian E.; Im, Seock-Ah; Barrios, Carlos; Bonnefoi, Herve; Gralow, Julie; Toi, Masakazu; Ellis, Paul A.; Gianni, Luca; Swain, Sandra M.; Im, Young-Hyuck; De Laurentiis, Michelino; Nowecki, Zbigniew; Huang, Chiun-Sheng; Fehrenbacher, Louis; Ito, Yoshinori; Shah, Jigna; Boulet, Thomas; Liu, Haiying; Macharia, Harrison; Trask, Peter; Song, Chunyan; Winer, Eric P. und Harbeck, Nadia
(2022):
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study.
In: Journal of Clinical Oncology, Bd. 40, Nr. 5: S. 438-448
2021
O'Shaughnessy, Joyce A.; Johnston, Stephen; Harbeck, Nadia; Toi, Masakazu; Im, Young-Hyuck; Reinisch, Mattea; Shao, Zhimin; Lehtinen, Pirkko Liisa Kellokumpu; Huang, Chiun-Sheng; Tryakin, Alexey; Goetz, Matthew; Rugo, Hope S.; Senkus, Elzbieta; Testa, Laura; Andersson, Michael; Tamura, Kenji; Steger, Guenther G.; Del Mastro, Lucia; Cox, Joanne; Forrester, Tammy; Sherwood, Sarah; Li, Xuelin; Wei, Ran; Martin, Miguel und Rastogi, Priya
(2021):
Primary Outcome Analysis of Invasive Disease-Free Survival for MonarchE: Abemaciclib Combined With Adjuvant Endocrine Therapy for High-Risk Early Breast Cancer.
In: Clinical Advances in Hematology & Oncology, Bd. 19, Nr. 2: S. 15-16
2020
Escala-Garcia, Maria; Abraham, Jean; Andrulis, Irene L.; Anton-Culver, Hoda; Arndt, Volker; Ashworth, Alan; Auer, Paul L.; Auvinen, Paivi; Beckmann, Matthias W.; Beesley, Jonathan; Behrens, Sabine; Benitez, Javier; Bermisheva, Marina; Blomqvist, Carl; Blot, William; Bogdanova, Natalia V.; Bojesen, Stig E.; Bolla, Manjeet K.; Borresen-Dale, Anne-Lise; Brauch, Hiltrud; Brenner, Hermann; Brucker, Sara Y.; Burwinkel, Barbara; Caldas, Carlos; Canzian, Federico; Chang-Claude, Jenny; Chanock, Stephen J.; Chin, Suet-Feung; Clarke, Christine L.; Couch, Fergus J.; Cox, Angela; Cross, Simon S.; Czene, Kamila; Daly, Mary B.; Dennis, Joe; Devilee, Peter; Dunn, Janet A.; Dunning, Alison M.; Dwek, Miriam; Earl, Helena M.; Eccles, Diana M.; Eliassen, A. Heather; Ellberg, Carolina; Evans, D. Gareth; Fasching, Peter A.; Figueroa, Jonine; Flyger, Henrik; Gago-Dominguez, Manuela; Gapstur, Susan M.; Garcia-Closas, Montserrat; Garcia-Saenz, Jose A.; Gaudet, Mia M.; George, Angela; Giles, Graham G.; Goldgar, David E.; Gonzalez-Neira, Anna; Grip, Mervi; Guenel, Pascal; Guo, Qi; Haiman, Christopher A.; Hakansson, Niclas; Hamann, Ute; Harrington, Patricia A.; Hiller, Louise; Hooning, Maartje J.; Hopper, John L.; Howell, Anthony; Huang, Chiun-Sheng; Huang, Guanmengqian; Hunter, David J.; Jakubowska, Anna; John, Esther M.; Kaaks, Rudolf; Kapoor, Pooja Middha; Keeman, Renske; Kitahara, Cari M.; Koppert, Linetta B.; Kraft, Peter; Kristensen, Vessela N.; Lambrechts, Diether; Le Marchand, Loic; Lejbkowicz, Flavio; Lindblom, Annika; Lubinski, Jan; Mannermaa, Arto; Manoochehri, Mehdi; Manoukian, Siranoush; Margolin, Sara; Martinez, Maria Elena; Maurer, Tabea; Mavroudis, Dimitrios; Meindl, Alfons; Milne, Roger L.; Mulligan, Anna Marie; Neuhausen, Susan L.; Nevanlinna, Heli; Newman, William G.; Olshan, Andrew F.; Olson, Janet E.; Olsson, Hakan; Orr, Nick; Peterlongo, Paolo; Petridis, Christos; Prentice, Ross L.; Presneau, Nadege; Punie, Kevin; Ramachandran, Dhanya; Rennert, Gad; Romero, Atocha; Sachchithananthan, Mythily; Saloustros, Emmanouil; Sawyer, Elinor J.; Schmutzler, Rita K.; Schwentner, Lukas; Scott, Christopher; Simard, Jacques; Sohn, Christof; Southey, Melissa C.; Swerdlow, Anthony J.; Tamimi, Rulla M.; Tapper, William J.; Teixeira, Manuel R.; Terry, Mary Beth; Thorne, Heather; Tollenaar, Rob A. E. M.; Tomlinson, Ian; Troester, Melissa A.; Truong, Therese; Turnbull, Clare; Vachon, Celine M.; Kolk, Lizet E. van der; Wang, Qin; Winqvist, Robert; Wolk, Alicja; Yang, Xiaohong R.; Ziogas, Argyrios; Pharoah, Paul D. P.; Hall, Per; Wessels, Lodewyk F. A.; Chenevix-Trench, Georgia; Bader, Gary D.; Doerk, Thilo; Easton, Douglas F.; Canisius, Sander und Schmidt, Marjanka K.
(2020):
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.
In: Nature Communications, Bd. 11, Nr. 1, 312
[PDF, 4MB]
2019
Hurvitz, Sara A.; Martin, Miguel; Jung, Kyung Hae; Huang, Chiun-Sheng; Harbeck, Nadia; Valero, Vicente; Stroyakovskiy, Daniil; Wildiers, Hans; Campone, Mario; Boileau, Jean-Francois; Fasching, Peter A.; Afenjar, Karen; Spera, Gonzalo; Lopez-Valverde, Vanesa; Song, Chunyan; Trask, Peter; Boulet, Thomas; Sparano, Joseph A.; Symmans, W. Fraser; Thompson, Alastair M. und Slamon, Dennis
(2019):
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study.
In: Journal of Clinical Oncology, Bd. 37, Nr. 25
2018
Hurvitz, Sara A.; Martin, Miguel; Symmans, W. Fraser; Jung, Kyung Hae; Huang, Chiun-Sheng; Thompson, Alastair M.; Harbeck, Nadia; Valero, Vicente; Stroyakovskiy, Daniil; Wildiers, Hans; Campone, Mario; Boileau, Jean-Francois; Beckmann, Matthias W.; Afenjar, Karen; Fresco, Rodrigo; Helms, Hans-Joachim; Xu, Jin; Lin, Yvonne G.; Sparano, Joseph und Slamon, Dennis
(2018):
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
In: Lancet Oncology, Bd. 19, Nr. 1: S. 115-126
2016
Harbeck, Nadia; Huang, Chiun-Sheng; Hurvitz, Sara; Yeh, Dah-Cherng; Shao, Zhimin; Im, Seock-Ah; Jung, Kyung Hae; Shen, Kunwei; Ro, Jungsil; Jassem, Jacek; Zhang, Qingyuan; Im, Young-Hyuck; Wojtukiewicz, Marek; Sun, Qiang; Chen, Shin-Cheh; Goeldner, Rainer-Georg; Uttenreuther-Fischer, Martina; Xu, Binghe und Piccart-Gebhart, Martine
(2016):
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial.
In: Lancet Oncology, Bd. 17, Nr. 3: S. 357-366